Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2415557122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Ling He und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095. Hauptthemen laut MEDLINE: Colforsin, Glioblastoma, Cell Differentiation, Brain Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Glioblastoma (GBM) is the deadliest brain cancer in adults, and all patients succumb to the tumor. While surgery followed by chemoradiotherapy delays disease progression, these treatments do not lead to tumor control, and targeted therapies or biologics have failed to further improve survival. Utilizing a transient radiation-induced state of multipotency, we used the adenylcyclase activator forskolin to alter the fate of irradiated glioma cells. The effects of the combined treatment on neuronal marker expression, cell cycle distribution, and proliferation were studied. Gene expression profiling was conducted using bulk RNA-seq. Changes in cell populations were investigated using single-cell RNA-seq. Effects on glioma stem cells (GSCs) were studied in extreme limiting dilution assays, and the effects on median survival were studied in both syngeneic and PDOX mouse models of GBM. The combined treatment induced the expression of neuronal markers in glioma cells, reduced proliferation, and led to a distinct gene expression profile. scRNA-seq revealed that the combined treatment forced glioma cells into a microglia- and neuron-like phenotype. In vivo, this treatment led to a loss of GSCs and prolonged median survival. Collectively, our data suggest that revisiting a differentiation therapy with forskolin in combination with radiation could lead to clinical benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA 90095.
- Jonsson Comprehensive Cancer Center at University of California, Los Angeles, CA 90095.
- Department of Biological Chemistry at University of California, Los Angeles, CA 90095.
- Department of Anesthesiology at University of California, Los Angeles, CA 90095.
- Neuropsychiatric Institute-Semel Institute for Neuroscience and Human Behavior at University of California, Los Angeles, CA 90095.
- Department of Neurosurgery, David Geffen School of Medicine at University of California, Los Angeles, CA 90095.
ORCID-Profile: Ling He, Daria Azizad, Angeliki Ioannidis, Aparna Bhaduri, Harley I Kornblum, Frank Pajonk
Förderung
- NCI NIH HHS
- NIH HHS
- NICHD NIH HHS
- NIH/NCI
- NIAMS NIH HHS
- NCRR NIH HHS
Zitieren
APA
He, L., Azizad, D., Bhat, K., Ioannidis, A., Hoffmann, C. J., Arambula, E., Eghbali, M., Bhaduri, A., Kornblum, H. I., & Pajonk, F. (2025). Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415557122
Vancouver
He L, Azizad D, Bhat K, Ioannidis A, Hoffmann CJ, Arambula E, et al. Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2415557122
BibTeX
@article{He2025,
author = {He, Ling and Azizad, Daria and Bhat, Kruttika and Ioannidis, Angeliki and Hoffmann, Carter J and Arambula, Evelyn and Eghbali, Mansoureh and Bhaduri, Aparna and Kornblum, Harley I and Pajonk, Frank},
title = {Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2415557122}
}
EUVIMED